Zentalis Pharmaceuticals IncNASDAQ:ZNTL
- LAST PRICE4.2300
- TODAY'S CHANGE (%)-0.1300 (-2.9817%)
- Bid / Lots4.1600/ 5
- Ask / Lots4.3000/ 4
- Open / Previous Close4.3000 / 4.3600
- Day Range
- 52 Week Range
- Volume4,838,253
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZNTL |
|---|---|---|
| 09:32 ET | 135993 | 4.27 |
| 09:34 ET | 6618 | 4.299 |
| 09:36 ET | 3058 | 4.32 |
| 09:38 ET | 19696 | 4.25 |
| 09:39 ET | 8963 | 4.2601 |
| 09:41 ET | 3994 | 4.2999 |
| 09:43 ET | 2743 | 4.295 |
| 09:45 ET | 6199 | 4.27 |
| 09:48 ET | 3746 | 4.25 |
| 09:50 ET | 17109 | 4.23 |
| 09:52 ET | 20656 | 4.18 |
| 09:54 ET | 3970 | 4.195 |
| 09:56 ET | 3662 | 4.17 |
| 09:57 ET | 8223 | 4.1815 |
| 09:59 ET | 7883 | 4.205 |
| 10:01 ET | 4317 | 4.1957 |
| 10:03 ET | 14791 | 4.2 |
| 10:06 ET | 12400 | 4.1891 |
| 10:08 ET | 3266 | 4.19 |
| 10:10 ET | 2228 | 4.24 |
| 10:12 ET | 14982 | 4.173 |
| 10:14 ET | 1592 | 4.18 |
| 10:15 ET | 17868 | 4.13 |
| 10:17 ET | 5894 | 4.18 |
| 10:19 ET | 2462 | 4.21 |
| 10:21 ET | 4060 | 4.2 |
| 10:24 ET | 1056 | 4.21 |
| 10:26 ET | 1521 | 4.22 |
| 10:28 ET | 2712 | 4.225 |
| 10:30 ET | 1616 | 4.205 |
| 10:32 ET | 3139 | 4.215 |
| 10:33 ET | 3787 | 4.2 |
| 10:35 ET | 1810 | 4.19 |
| 10:37 ET | 300 | 4.185 |
| 10:39 ET | 2521 | 4.175 |
| 10:42 ET | 2623 | 4.18 |
| 10:44 ET | 1310 | 4.19 |
| 10:46 ET | 4357 | 4.19 |
| 10:48 ET | 610 | 4.19 |
| 10:50 ET | 808 | 4.16 |
| 10:51 ET | 9147 | 4.15 |
| 10:53 ET | 11187 | 4.16 |
| 10:55 ET | 14078 | 4.17 |
| 10:57 ET | 1216 | 4.16 |
| 11:00 ET | 352 | 4.15 |
| 11:02 ET | 1275 | 4.14 |
| 11:04 ET | 5053 | 4.092 |
| 11:06 ET | 3335 | 4.12 |
| 11:08 ET | 1900 | 4.11 |
| 11:09 ET | 3974 | 4.1 |
| 11:11 ET | 3552 | 4.1 |
| 11:13 ET | 2264 | 4.11 |
| 11:15 ET | 4313 | 4.13 |
| 11:18 ET | 2392 | 4.125 |
| 11:20 ET | 1386 | 4.14 |
| 11:26 ET | 1662 | 4.1385 |
| 11:27 ET | 4580 | 4.16 |
| 11:29 ET | 650 | 4.15 |
| 11:31 ET | 918 | 4.13 |
| 11:33 ET | 1800 | 4.109027 |
| 11:36 ET | 2481 | 4.13 |
| 11:38 ET | 2662 | 4.15 |
| 11:40 ET | 7404 | 4.14 |
| 11:42 ET | 1077 | 4.1499 |
| 11:44 ET | 1453 | 4.15 |
| 11:45 ET | 1000 | 4.155 |
| 11:47 ET | 3402 | 4.16 |
| 11:49 ET | 200 | 4.18 |
| 11:51 ET | 407 | 4.18 |
| 11:54 ET | 1923 | 4.17 |
| 11:56 ET | 1600 | 4.175 |
| 11:58 ET | 3591 | 4.185 |
| 12:00 ET | 600 | 4.18 |
| 12:02 ET | 900 | 4.16 |
| 12:03 ET | 3568 | 4.17 |
| 12:05 ET | 400 | 4.165 |
| 12:07 ET | 732 | 4.18 |
| 12:09 ET | 200 | 4.18 |
| 12:12 ET | 1700 | 4.18 |
| 12:14 ET | 2632 | 4.181 |
| 12:16 ET | 109 | 4.1812 |
| 12:18 ET | 1020 | 4.1899 |
| 12:20 ET | 4434 | 4.195 |
| 12:21 ET | 1614 | 4.2 |
| 12:23 ET | 1805 | 4.2 |
| 12:25 ET | 900 | 4.1975 |
| 12:27 ET | 1679 | 4.2 |
| 12:30 ET | 1500 | 4.19 |
| 12:32 ET | 742 | 4.185 |
| 12:34 ET | 2937 | 4.17 |
| 12:36 ET | 100 | 4.17 |
| 12:38 ET | 949 | 4.169 |
| 12:39 ET | 4393 | 4.1675 |
| 12:41 ET | 2800 | 4.175 |
| 12:43 ET | 1776 | 4.17 |
| 12:45 ET | 100 | 4.165 |
| 12:48 ET | 1905 | 4.17 |
| 12:50 ET | 4909 | 4.18 |
| 12:52 ET | 400 | 4.185 |
| 12:54 ET | 779 | 4.19 |
| 12:56 ET | 1386 | 4.19 |
| 12:57 ET | 200 | 4.185 |
| 12:59 ET | 4357 | 4.18 |
| 01:01 ET | 1520 | 4.18 |
| 01:06 ET | 1200 | 4.165 |
| 01:08 ET | 14527 | 4.175 |
| 01:10 ET | 7906 | 4.195 |
| 01:12 ET | 7097 | 4.2 |
| 01:14 ET | 1013 | 4.185 |
| 01:15 ET | 300 | 4.19 |
| 01:17 ET | 601 | 4.185 |
| 01:19 ET | 5062 | 4.175 |
| 01:21 ET | 4449 | 4.19 |
| 01:24 ET | 1580 | 4.17 |
| 01:26 ET | 800 | 4.16 |
| 01:28 ET | 2654 | 4.18 |
| 01:30 ET | 3392 | 4.13 |
| 01:32 ET | 2703 | 4.13 |
| 01:33 ET | 900 | 4.14 |
| 01:35 ET | 1999 | 4.15 |
| 01:37 ET | 6608 | 4.16 |
| 01:39 ET | 5050 | 4.16 |
| 01:42 ET | 765 | 4.15 |
| 01:44 ET | 800 | 4.16 |
| 01:46 ET | 2143 | 4.16 |
| 01:48 ET | 762 | 4.155 |
| 01:50 ET | 729 | 4.15 |
| 01:51 ET | 2556 | 4.14 |
| 01:53 ET | 4582 | 4.14 |
| 01:55 ET | 3359 | 4.14 |
| 01:57 ET | 1064 | 4.14 |
| 02:00 ET | 3319 | 4.119 |
| 02:02 ET | 3134 | 4.125 |
| 02:04 ET | 1898 | 4.11 |
| 02:06 ET | 5988 | 4.105 |
| 02:08 ET | 3784 | 4.1 |
| 02:09 ET | 2775 | 4.0975 |
| 02:11 ET | 2091 | 4.095 |
| 02:13 ET | 12576 | 4.09 |
| 02:15 ET | 900 | 4.095 |
| 02:18 ET | 3490 | 4.09 |
| 02:20 ET | 17150 | 4.0801 |
| 02:22 ET | 18106 | 4.0601 |
| 02:24 ET | 13203 | 4.04 |
| 02:26 ET | 10692 | 4.05 |
| 02:27 ET | 2769 | 4.05 |
| 02:29 ET | 6020 | 4.05 |
| 02:31 ET | 8036 | 4.045 |
| 02:33 ET | 7814 | 4.07 |
| 02:36 ET | 8535 | 4.09 |
| 02:38 ET | 1684 | 4.0901 |
| 02:40 ET | 24001 | 4.1 |
| 02:42 ET | 4641 | 4.11 |
| 02:44 ET | 1400 | 4.1 |
| 02:45 ET | 3264 | 4.1 |
| 02:47 ET | 3781 | 4.11 |
| 02:49 ET | 11393 | 4.115 |
| 02:51 ET | 3689 | 4.1 |
| 02:54 ET | 3000 | 4.1001 |
| 02:56 ET | 10034 | 4.1 |
| 02:58 ET | 4194 | 4.09 |
| 03:00 ET | 3389 | 4.08 |
| 03:02 ET | 8452 | 4.075 |
| 03:03 ET | 5369 | 4.085 |
| 03:05 ET | 7107 | 4.08 |
| 03:07 ET | 7680 | 4.05 |
| 03:09 ET | 6811 | 4.04 |
| 03:12 ET | 5977 | 4.05 |
| 03:14 ET | 4380 | 4.0389 |
| 03:16 ET | 7099 | 4.055 |
| 03:18 ET | 3506 | 4.055 |
| 03:20 ET | 925 | 4.055 |
| 03:21 ET | 5645 | 4.06 |
| 03:23 ET | 12234 | 4.055 |
| 03:25 ET | 8655 | 4.055 |
| 03:27 ET | 6600 | 4.09 |
| 03:30 ET | 17979 | 4.155 |
| 03:32 ET | 12957 | 4.185 |
| 03:34 ET | 6828 | 4.175 |
| 03:36 ET | 7380 | 4.185 |
| 03:38 ET | 29019 | 4.165 |
| 03:39 ET | 8030 | 4.18 |
| 03:41 ET | 14908 | 4.175 |
| 03:43 ET | 8230 | 4.17 |
| 03:45 ET | 886 | 4.17 |
| 03:48 ET | 6429 | 4.16 |
| 03:50 ET | 14956 | 4.14 |
| 03:52 ET | 8468 | 4.125 |
| 03:54 ET | 24516 | 4.13 |
| 03:56 ET | 27926 | 4.16 |
| 03:57 ET | 41117 | 4.165 |
| 03:59 ET | 3074842 | 4.23 |
Sep 16, 2024
Kuehn Law Encourages Investors of Zentalis Pharmaceuticals, Inc. to Contact Law Firm, from 9:38PM ET on Monday Sep 16, 2024 by Dow Jones
9:38PM ET on Monday Sep 16, 2024 by Dow JonesDJ Zentalis Pharmaceuticals Price Target Maintained With a $20.00/Share by Oppenheimer, from 2:03PM ET on Monday Sep 16, 2024 by Dow Jones
2:03PM ET on Monday Sep 16, 2024 by Dow JonesDJ Zentalis Shares Rise After U.S. FDA Lifts Hold on Azenosertib Studies, from 7:37AM ET on Monday Sep 16, 2024 by Dow Jones
7:37AM ET on Monday Sep 16, 2024 by Dow JonesZentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies, from 7:00AM ET on Monday Sep 16, 2024 by Dow Jones
7:00AM ET on Monday Sep 16, 2024 by Dow Jones
Sep 9, 2024
Zentalis Pharmaceuticals to Present Preclinical Azenosertib Data at ESMO 2024, from 7:00AM ET on Monday Sep 09, 2024 by Dow Jones
7:00AM ET on Monday Sep 09, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zentalis Pharmaceuticals Inc | 310.0M | -1.5x | --- |
Solid Biosciences Inc | 308.8M | -2.4x | --- |
PepGen Inc | 304.7M | -2.8x | --- |
Biomea Fusion Inc | 315.4M | -2.2x | --- |
enGene Holdings Inc | 316.6M | -1.5x | --- |
Kyverna Therapeutics Inc | 298.6M | 0.0x | --- |
Company Information
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company’s lead product candidate includes azenosertib (ZN-c3), which is a WEE1 inhibitor for advanced solid tumors and hematological malignancies. The Company is also developing a BCL-2 inhibitor, ZN-d5, for hematological malignancies and related disorders. ZN-d5 is being evaluated in combination with azenosertib in a Phase I/II dose escalation clinical trial in patients with R/R acute myeloid leukemia (AML) (ZN-d5-004C). The Company is also advancing its research on protein degraders and other undisclosed targets using its Integrated Discovery Engine.
Contact Information
- Headquarters
- 10275 Science Center Drive, Suite 200SAN DIEGO, CA, United States 92121
- Phone
- 858-263-4333
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Johnson
- President, Interim Chief Financial Officer, Interim Treasurer, Executive Director
- Cam Gallagher
- President, Chief Executive Officer, Director
- Kimberly Blackwell
- Chief Scientific Officer
- Mark Lackner,
- Chief Medical Officer
- Diana Hausman
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $310.0M |
|---|---|
Revenue (TTM) | $40.6M |
Shares Outstanding | 71.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.69 |
EPS | $-2.75 |
Book Value | $6.18 |
P/E Ratio | -1.5x |
Price/Sales (TTM) | 7.6 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -543.77% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
